{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:02:00Z","timestamp":1790146920220,"version":"4.0.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jogoh.2018.02.001","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T12:49:59Z","timestamp":1519217399000},"page":"197-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Management of red blood cell alloimmunization in pregnancy"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4142-5526","authenticated-orcid":false,"given":"L.","family":"Ghesqui\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Garabedian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Coulon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Verpillat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Rakza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Wibaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Delsalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Subtil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vaast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Debarge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogoh.2018.02.001_bib0395","first-page":"35","article-title":"Epidemiology of anti-D alloimmunization during pregnancy","author":"Branger","year":"2006","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0400","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/AOG.0b013e31826d7dc1","article-title":"Management and prevention of red cell alloimmunization in pregnancy: a systematic review","volume":"120","author":"Moise","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0405","unstructured":"Poissonnier M-H, Maynier M, Lachaux V de, Chavini\u00e9 J, Souli\u00e9 J-C, Brossard Y, et al. Incompatibilit\u00e9 f\u0153tomaternelle \u00e9rythrocytaire; 1998. http:\/\/www.em-premium.com.doc-distant.univ-lille2.fr\/article\/1562\/resultatrecherche\/2. [cited 2015 Aug 6]."},{"key":"10.1016\/j.jogoh.2018.02.001_bib0410","first-page":"1","article-title":"Incompatibilit\u00e9s f\u0153tomaternelles \u00e9rythrocytaires","volume":"7","author":"Cortey","year":"2012","journal-title":"EMC Pediatrie"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0415","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0368-2315(04)96605-7","article-title":"Kell alloimmunization in pregnancy","volume":"33","author":"Gariod","year":"2004","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0420","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0425","first-page":"23","article-title":"Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women","volume":"8","author":"Rouillac-Le Sciellour","year":"2004","journal-title":"Mol Diagn J Devoted Underst Hum Dis Clin Appl Mol Biol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0430","first-page":"215","author":"Vivanti","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0435","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12611-013-0259-z","article-title":"Apport du g\u00e9notypage f\u0153tal non invasif sur sang maternel pour la prise en charge des allo-immunisations anti\u00e9rythrocytaires et la pr\u00e9vention Rh\u00e9sus","volume":"5","author":"Mailloux","year":"2013","journal-title":"Rev Med Perinat"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0440","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1471-0528.2008.01744.x","article-title":"Noninvasive fetal RhCE genotyping from maternal blood","volume":"116","author":"Geifman-Holtzman","year":"2009","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0445","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.gyobfe.2010.01.012","article-title":"Follow-up of pregnancies with red cell alloimmunisation: state-of-the art","volume":"38","author":"Carbonne","year":"2010","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0450","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200001063420102","article-title":"Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses","volume":"342","author":"Mari","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0455","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/uog.12371","article-title":"ISUOG practice guidelines: use of Doppler ultrasonography in obstetrics","volume":"41","author":"Bhide","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0460","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ajog.2008.11.002","article-title":"Angle correction can be used to measure peak systolic velocity in the fetal middle cerebral artery","volume":"200","author":"Ruma","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0465","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.ajog.2004.03.018","article-title":"The effect of fetal behavioral states on middle cerebral artery peak systolic velocity","volume":"191","author":"Sallout","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0470","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/AOG.0b013e3181a4b4b5","article-title":"The effect of fetal heart rate on the peak systolic velocity of the fetal middle cerebral artery","volume":"113","author":"Swartz","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0475","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1471-0528.2002.01314.x","article-title":"Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: a prospective multicentre trial with intention-to-treat","volume":"109","author":"Zimmermann","year":"2002","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0480","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0002-9378(16)36265-2","article-title":"Liquor amnii analysis in the management of the pregnancy complicated by rhesus sensitization","volume":"82","author":"Liley","year":"1961","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0485","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1056\/NEJMoa052855","article-title":"Doppler ultrasonography versus amniocentesis to predict fetal anemia","volume":"355","author":"Oepkes","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0490","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejogrb.2015.06.016","article-title":"Management of severe fetal anemia by Doppler measurement of middle cerebral artery: are there other benefits than reducing invasive procedures?","volume":"192","author":"Garabedian","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0495","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/bmj.2.5365.1107","article-title":"Intrauterine transfusion of foetus in haemolytic disease","volume":"2","author":"Liley","year":"1963","journal-title":"Br Med J"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0500","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/AOG.0b013e318235e3bb","article-title":"Management of very early fetal anemia resulting from red cell alloimmunization before 20 weeks of gestation","volume":"118","author":"Canlorbe","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0505","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0002-9378(84)90683-5","article-title":"The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions","volume":"150","author":"Rodeck","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0510","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000020813","article-title":"A simple method to estimate volume for fetal intravascular transfusions","volume":"13","author":"Giannina","year":"1998","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0515","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bpobgyn.2007.08.005","article-title":"Fetal anaemia: diagnosis and management","volume":"22","author":"Brennand","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0520","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1515\/jpm-2012-0093","article-title":"Therapeutic management of fetal anemia: review of standard practice and alternative treatment options","volume":"41","author":"Papantoniou","year":"2013","journal-title":"J Perinat Med"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0525","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJM198605293142207","article-title":"In utero exchange transfusion by direct intravascular injection in severe erythroblastosis fetalis","volume":"314","author":"Grannum","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0530","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0002-9378(89)90386-4","article-title":"Two hundred intrauterine exchange transfusions in severe blood incompatibilities","volume":"161","author":"Poissonnier","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0535","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejogrb.2014.05.008","article-title":"Is intrauterine exchange transfusion a safe procedure for management of fetal anaemia?","volume":"179","author":"Garabedian","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0540","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejogrb.2016.03.037","article-title":"In utero treatment of severe fetal anemia resulting from fetomaternal red blood cell incompatibility: a comparison of simple transfusion and exchange transfusion","volume":"201","author":"Guilbaud","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0545","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ajog.2005.06.078","article-title":"Correlation between middle cerebral artery peak systolic velocity and fetal hemoglobin after 2 previous intrauterine transfusions","volume":"193","author":"Mari","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0550","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1067\/mob.2001.118161","article-title":"Doppler ultrasound velocimetry for timing the second intrauterine transfusion in fetuses with anemia from red cell alloimmunization","volume":"185","author":"Detti","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0555","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/uog.14772","article-title":"Determination of the optimal timing of serial in utero transfusions in red blood cell alloimmuniation","volume":"46","author":"Friszer","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0560","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.ajog.2006.03.060","article-title":"Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions","volume":"195","author":"Scheier","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0565","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/trf.13980","article-title":"Should optimal timing between two intrauterine transfusions be based on estimated daily decrease of hemoglobin or on measurement of fetal middle cerebral artery peak systolic velocity?","volume":"57","author":"Ghesqui\u00e8re","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0570","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ajog.2015.01.059","article-title":"Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline: the fetus at risk for anemia\u00a0\u2013\u00a0diagnosis and management","volume":"212","author":"Mari","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0575","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0301-2115(00)00430-9","article-title":"Benefits and risks of fetal red cell transfusion after 32 weeks gestation","volume":"92","author":"Klumper","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0580","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ajog.2004.06.063","article-title":"Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red cell alloimmunization","volume":"192","author":"Van Kamp","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0585","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/1471-0528.12063","article-title":"Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation","volume":"120","author":"Lindenburg","year":"2013","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0590","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/uog.17319","article-title":"Complications of intrauterine intravascular blood transfusions: lessons learned after 1678 procedures","volume":"50","author":"Zwiers","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0595","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/17474086.2017.1305265","article-title":"Intrauterine transfusion and noninvasive treatment options for hemolytic disease of the fetus and newborn\u00a0\u2013\u00a0review on current management and outcome","volume":"10","author":"Zwiers","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0600","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1515\/jpme.1994.22.5.415","article-title":"Repeated direct fetal intravascular high-dose immunoglobulin therapy for the treatment of Rh hemolytic disease","volume":"22","author":"Alonso","year":"1994","journal-title":"J Perinat Med"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0605","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(85)92451-1","article-title":"Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin","volume":"1","author":"Berlin","year":"1985","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0610","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1067\/mai.2001.117821","article-title":"Obstetric uses of intravenous immunoglobulin: successes, failures, and promises","volume":"108","author":"Branch","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0615","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00006254-198901000-00003","article-title":"Intravenous gamma globulin in pregnancy: a review","volume":"44","author":"Sacher","year":"1989","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0620","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3109\/00016349509021196","article-title":"Alloimmunization during pregnancy treated with high-dose intravenous immunoglobulin. Effects on fetal hemoglobin concentration and anti-D concentrations in the mother and fetus","volume":"74","author":"Gottvall","year":"1995","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0625","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1515\/jpme.1997.25.1.85","article-title":"High-dose gamma globulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease","volume":"25","author":"Voto","year":"1997","journal-title":"J Perinat Med"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0630","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJM198802253180816","article-title":"High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization","volume":"318","author":"De la C\u00e1mara","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0635","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1423-0410.1991.tb00944.x","article-title":"High-dose intravenous IgG for the treatment of severe rhesus alloimmunization","volume":"61","author":"Margulies","year":"1991","journal-title":"Vox Sang"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0640","first-page":"703","article-title":"High-dose intravenous gamma globulin: does it have a role in the treatment of severe erythroblastosis fetalis?","volume":"76","author":"Chitkara","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0645","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000353236","article-title":"Direct fetal intravenous immunoglobulin infusion as an adjunct to intrauterine fetal blood transfusion in rhesus-allommunized pregnancies: a pilot study","volume":"34","author":"Deka","year":"2013","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0650","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1046\/j.1537-2995.1999.39111235.x","article-title":"Immunoglobulin administration to fetuses with anemia due to alloimmunization to D","volume":"39","author":"Ulm","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0655","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000097661","article-title":"Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease","volume":"63","author":"Kriplani","year":"2007","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0660","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00006254-199703000-00022","article-title":"Intravenous immune globulin in the management of severe Rh D hemolytic disease","volume":"52","author":"Porter","year":"1997","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0665","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.ajog.2005.05.048","article-title":"The cost effectiveness of empiric intravenous immunoglobulin for the antepartum treatment of fetal and neonatal alloimmune thrombocytopenia","volume":"193","author":"Thung","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0670","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the seventh special issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0675","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/00003081-199106000-00010","article-title":"Antenatal suppression of Rh alloimmunization","volume":"34","author":"Bowman","year":"1991","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0680","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00003081-198206000-00011","article-title":"The potential role of immunosuppression, plasmapheresis, and desensitization as treatment modalities for Rh immunization","volume":"25","author":"Caudle","year":"1982","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0685","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1136\/bmj.280.6231.1569","article-title":"Adverse effect of plasma exchange on anti-D production in rhesus immunisation owing to removal of inhibitory factors","volume":"280","author":"Barclay","year":"1980","journal-title":"Br Med J"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0690","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.transci.2015.11.004","article-title":"Therapeutic apheresis in pregnancy: general considerations and current practice","volume":"53","author":"Marson","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0695","article-title":"Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion","author":"Nwogu","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0700","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1111\/trf.12633","article-title":"Therapeutic plasma exchange and intravenous immunoglobulin as primary therapy for D alloimmunization in pregnancy precludes the need for intrauterine transfusion","volume":"54","author":"Bellone","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0705","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jca.20288","article-title":"Early plasmapheresis followed by high-dose \u03b3-globulin treatment saved a severely Rho-incompatible pregnancy","volume":"26","author":"Isojima","year":"2011","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0710","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ajog.2004.08.016","article-title":"Antenatal maternal administration of phenobarbital for the prevention of exchange transfusion in neonates with hemolytic disease of the fetus and newborn","volume":"192","author":"Trevett","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0715","first-page":"CD005541","article-title":"Antenatal phenobarbital for reducing neonatal jaundice after red cell isoimmunization","author":"Thomas","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0720","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004074.pub2","article-title":"Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes","volume":"2","author":"McDonald","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0725","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.arcped.2013.06.016","article-title":"Int\u00e9r\u00eat du clampage retard\u00e9 du cordon ombilical chez le nouveau-n\u00e9","volume":"20","author":"Menget","year":"2013","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0730","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1542\/peds.2005-1706","article-title":"Delayed cord clamping in very preterm infants reduces the incidence of intraventricular hemorrhage and late-onset sepsis: a randomized, controlled trial","volume":"117","author":"Mercer","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0735","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/AOG.0000000000000122","article-title":"Time to implement delayed cord clamping","volume":"123","author":"McAdams","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0740","doi-asserted-by":"crossref","first-page":"e20153236","DOI":"10.1542\/peds.2015-3236","article-title":"Benefits of delayed cord clamping in red blood cell alloimmunization","volume":"137","author":"Garabedian","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0745","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1067\/mob.2001.116690","article-title":"The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment","volume":"185","author":"Van Kamp","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0750","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.0001-6349.2004.00394.x","article-title":"Treatment of fetal anemia due to red cell alloimmunization with intrauterine transfusions in the Netherlands, 1988\u20131999","volume":"83","author":"Van Kamp","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0755","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.earlhumdev.2011.07.003","article-title":"Long-term neurodevelopmental outcome after intrauterine transfusion for fetal anemia","volume":"87","author":"Van Klink","year":"2011","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0760","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.earlhumdev.2012.02.013","article-title":"Brain ultrasound findings in neonates treated with intrauterine transfusion for fetal anaemia","volume":"88","author":"Leijser","year":"2012","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0765","first-page":"206","article-title":"Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus\/newborn: the LOTUS study","author":"Lindenburg","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0770","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S0221-0363(06)74144-0","article-title":"MRI aspects of anoxic-ischemic encephalopathy of the term and premature newborn","volume":"87","author":"Anthonioz","year":"2006","journal-title":"J Radiol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0775","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/AOG.0b013e3181656a11","article-title":"Prenatal diagnosis of anoxic cerebral lesions caused by profound fetal anemia secondary to maternal red blood cell alloimmunization","volume":"112","author":"Carbonne","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.02.001_bib0780","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/uog.1035","article-title":"Sonographic demonstration of brain injury in fetuses with severe red blood cell alloimmunization undergoing intrauterine transfusions","volume":"23","author":"Ghi","year":"2004","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784718300692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784718300692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T07:51:07Z","timestamp":1603871467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784718300692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S2468784718300692"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2018.02.001","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of red blood cell alloimmunization in pregnancy","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2018.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}